Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $3,575 | 10 | 79.0% |
| Food and Beverage | $950.33 | 29 | 21.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Stryker Corporation | $2,372 | 8 | $0 (2019) |
| Intuitive Surgical, Inc. | $1,674 | 11 | $0 (2021) |
| Celgene Corporation | $127.78 | 1 | $0 (2017) |
| Axonics, Inc. | $35.67 | 2 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $33.51 | 2 | $0 (2024) |
| Amgen Inc. | $32.62 | 2 | $0 (2019) |
| Intercept Pharmaceuticals, Inc. | $28.31 | 1 | $0 (2024) |
| VERTEX PHARMACEUTICALS INCORPORATED | $27.27 | 1 | $0 (2024) |
| Axonics Modulation Technologies, Inc. | $25.12 | 2 | $0 (2020) |
| UPSHER-SMITH LABORATORIES LLC | $24.11 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $116.37 | 5 | Intercept Pharmaceuticals, Inc. ($28.31) |
| 2023 | $37.08 | 2 | Axonics, Inc. ($18.56) |
| 2022 | $56.62 | 3 | UPSHER-SMITH LABORATORIES LLC ($24.11) |
| 2021 | $54.49 | 2 | Intuitive Surgical, Inc. ($35.27) |
| 2020 | $25.12 | 2 | Axonics Modulation Technologies, Inc. ($25.12) |
| 2019 | $1,292 | 10 | Stryker Corporation ($1,223) |
| 2018 | $2,815 | 14 | Intuitive Surgical, Inc. ($1,638) |
| 2017 | $127.78 | 1 | Celgene Corporation ($127.78) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/21/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $27.27 | General |
| 08/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/14/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 02/13/2024 | Kerecis Limited | Kerecis Omega3 SurgiClose (Device), Kerecis Omega3 Marigen, Kerecis Omega3 GraftGuide | Food and Beverage | Cash or cash equivalent | $20.59 | General |
| Category: Wound Care | ||||||
| 01/09/2024 | Ethicon US, LLC | Echelon Circular (Device), Echelon Flex, Harmonic | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Endo-Mechanical | ||||||
| 10/30/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Gastroenterology | ||||||
| 03/07/2023 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Urology | ||||||
| 11/04/2022 | UPSHER-SMITH LABORATORIES LLC | ZEMBRACE SYMTOUCH (Drug), TOSYMRA | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: NEUROLOGY | ||||||
| 09/20/2022 | Integra LifeSciences Corporation | SURGIMEND (Device) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Recon-Skin and Wound | ||||||
| 05/17/2022 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Urology | ||||||
| 11/30/2021 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $19.22 | General |
| Category: GI | ||||||
| 10/19/2021 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $35.27 | General |
| Category: SURGERY | ||||||
| 05/06/2020 | Axonics Modulation Technologies, Inc. | Axonics r-SNM System (Device) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: Urology | ||||||
| 03/09/2020 | Axonics Modulation Technologies, Inc. | Axonics r-SNM System (Device) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Urology | ||||||
| 10/03/2019 | Stryker Corporation | INFRAVISION IMAGING SYSTEM (Device) | Travel and Lodging | Cash or cash equivalent | $728.02 | General |
| Category: LAPAROSCOPY | ||||||
| 09/24/2019 | Stryker Corporation | INFRAVISION IMAGING SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $41.44 | General |
| Category: LAPAROSCOPY | ||||||
| 09/24/2019 | Stryker Corporation | INFRAVISION IMAGING SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $24.89 | General |
| Category: LAPAROSCOPY | ||||||
| 09/18/2019 | Stryker Corporation | INFRAVISION IMAGING SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $123.08 | General |
| Category: LAPAROSCOPY | ||||||
| 09/09/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Neuroscience | ||||||
| 08/23/2019 | Stryker Corporation | INFRAVISION IMAGING SYSTEM (Device) | Travel and Lodging | Cash or cash equivalent | $204.00 | General |
| Category: LAPAROSCOPY | ||||||
| 08/23/2019 | Stryker Corporation | INFRAVISION IMAGING SYSTEM (Device) | Travel and Lodging | Cash or cash equivalent | $102.00 | General |
| Category: LAPAROSCOPY | ||||||
| 08/14/2019 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Neuroscience | ||||||
| 06/21/2019 | Promius Pharma LLC | ZEMBRACE SYMTOUCH (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Neurology | ||||||
| 12/11/2018 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: SURGERY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 894 | 921 | $644,345 | $135,721 |
| 2022 | 22 | 906 | 948 | $704,747 | $150,288 |
| 2021 | 25 | 965 | 1,025 | $663,750 | $150,499 |
| 2020 | 23 | 947 | 1,003 | $647,533 | $146,481 |
All Medicare Procedures & Services
90 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 140 | 140 | $124,740 | $19,985 | 16.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 86 | 88 | $93,016 | $19,431 | 20.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 95 | 95 | $114,190 | $18,485 | 16.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 112 | 112 | $64,400 | $18,096 | 28.1% |
| 46260 | Removal of multiple hemorrhoid groups | Facility | 2023 | 28 | 28 | $38,931 | $11,794 | 30.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 55 | 60 | $23,940 | $8,434 | 35.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 30 | 30 | $35,035 | $5,758 | 16.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 77 | 80 | $46,880 | $5,578 | 11.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 58 | 64 | $12,928 | $4,636 | 35.9% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2023 | 14 | 17 | $12,767 | $3,823 | 29.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $12,908 | $3,739 | 29.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 26 | $7,722 | $2,713 | 35.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 17 | 17 | $12,298 | $2,612 | 21.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 26 | 26 | $7,800 | $2,287 | 29.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 16 | 16 | $9,120 | $2,165 | 23.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 40 | 44 | $5,324 | $2,008 | 37.7% |
| 44213 | Partial release of large bowel and partial removal of large bowel using an endoscope | Facility | 2023 | 11 | 11 | $6,666 | $1,799 | 27.0% |
| 46600 | Diagnostic exam of anus using an endoscope | Office | 2023 | 12 | 15 | $3,720 | $1,451 | 39.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 13 | 13 | $2,665 | $777.79 | 29.2% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $9,295 | $146.26 | 1.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 161 | 162 | $142,866 | $21,714 | 15.2% |
| 44207 | Partial removal of large bowel and reattachment to rectum using an endoscope | Facility | 2022 | 11 | 11 | $83,839 | $19,280 | 23.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 74 | 76 | $80,332 | $15,931 | 19.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 75 | 75 | $90,150 | $14,714 | 16.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 81 | 81 | $46,575 | $14,583 | 31.3% |
About Dr. Susan Cera, MD
Dr. Susan Cera, MD is a Colon & Rectal Surgery healthcare provider based in Naples, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245280320.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Susan Cera, MD has received a total of $4,525 in payments from pharmaceutical and medical device companies, with $116.37 received in 2024. These payments were reported across 39 transactions from 18 companies. The most common payment nature is "Travel and Lodging" ($3,575).
As a Medicare-enrolled provider, Cera has provided services to 3,712 Medicare beneficiaries, totaling 3,897 services with total Medicare billing of $582,990. Data is available for 4 years (2020–2023), covering 90 distinct procedure/service records.
Practice Information
- Specialty Colon & Rectal Surgery
- Location Naples, FL
- Active Since 05/11/2006
- Last Updated 09/15/2020
- Taxonomy Code 208C00000X
- Entity Type Individual
- NPI Number 1245280320
Products in Payments
- Da Vinci Surgical System (Device) $1,674
- INFRAVISION IMAGING SYSTEM (Device) $1,223
- 1588 HD 3 CHIP CAMERA (Device) $1,148
- GED-0301 (Drug) $127.78
- ZEMBRACE SYMTOUCH (Drug) $44.12
- Axonics (Device) $35.67
- Aimovig (Biological) $32.62
- OCALIVA (Drug) $28.31
- Axonics r-SNM System (Device) $25.12
- Echelon Circular (Device) $23.47
- Kerecis Omega3 SurgiClose (Device) $20.59
- Linzess (Drug) $19.22
- XIFAXAN (Drug) $18.52
- Trintellix (Drug) $16.78
- ENTYVIO (Biological) $16.73
- VYVANSE (Drug) $15.96
- SURGIMEND (Device) $15.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.